Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke) - PubMed (original) (raw)

. 2008 Dec;73(12):1288-99.

doi: 10.1134/s000629790812002x.

I V Barskov, M V Egorov, N K Isaev, V I Kapelko, A V Kazachenko, V I Kirpatovsky, S V Kozlovsky, V L Lakomkin, S B Levina, O I Pisarenko, E Y Plotnikov, V B Saprunova, L I Serebryakova, M V Skulachev, E V Stelmashook, I M Studneva, O V Tskitishvili, A K Vasilyeva, I V Victorov, D B Zorov, V P Skulachev

Affiliations

• PMID: 19120015
• DOI: 10.1134/s000629790812002x

Free article

Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke)

L E Bakeeva et al. Biochemistry (Mosc). 2008 Dec.

Free article

Abstract

Effects of 10-(6'-plastoquinonyl) decyltriphenylphosphonium (SkQ1) and 10-(6'-plastoquinonyl) decylrhodamine 19 (SkQR1) on rat models of H2O2- and ischemia-induced heart arrhythmia, heart infarction, kidney ischemia, and stroke have been studied ex vivo and in vivo. In all the models listed, SkQ1 and/or SkQR1 showed pronounced protective effect. Supplementation of food with extremely low SkQ1 amount (down to 0.02 nmol SkQ1/kg per day for 3 weeks) was found to abolish the steady heart arrhythmia caused by perfusion of isolated rat heart with H2O2 or by ischemia/reperfusion. Higher SkQ1 (125-250 nmol/kg per day for 2-3 weeks) was found to decrease the heart infarction region induced by an in vivo ischemia/reperfusion and lowered the blood levels of lactate dehydrogenase and creatine kinase increasing as a result of ischemia/reperfusion. In single-kidney rats, ischemia/reperfusion of the kidney was shown to kill the majority of the animals in 2-4 days, whereas one injection of SkQ1 or SkQR1 (1 micromol/kg a day before ischemia) saved lives of almost all treated rats. Effect of SkQR1 was accompanied by decrease in ROS (reactive oxygen species) level in kidney cells as well as by partial or complete normalization of blood creatinine and of some other kidney-controlled parameters. On the other hand, this amount of SkQ1 (a SkQ derivative of lower membrane-penetrating ability than SkQR1) saved the life but failed to normalize ROS and creatinine levels. Such an effect indicates that death under conditions of partial kidney dysfunction is mediated by an organ of vital importance other than kidney, the organ in question being an SkQ1 target. In a model of compression brain ischemia/reperfusion, a single intraperitoneal injection of SkQR1 to a rat (1 micromol/kg a day before operation) effectively decreased the damaged brain area. SkQ1 was ineffective, most probably due to lower permeability of the blood-brain barrier to this compound.

PubMed Disclaimer

Similar articles

• An attempt to prevent senescence: a mitochondrial approach.
  Skulachev VP, Anisimov VN, Antonenko YN, Bakeeva LE, Chernyak BV, Erichev VP, Filenko OF, Kalinina NI, Kapelko VI, Kolosova NG, Kopnin BP, Korshunova GA, Lichinitser MR, Obukhova LA, Pasyukova EG, Pisarenko OI, Roginsky VA, Ruuge EK, Senin II, Severina II, Skulachev MV, Spivak IM, Tashlitsky VN, Tkachuk VA, Vyssokikh MY, Yaguzhinsky LS, Zorov DB. Skulachev VP, et al. Biochim Biophys Acta. 2009 May;1787(5):437-61. doi: 10.1016/j.bbabio.2008.12.008. Epub 2008 Dec 29. Biochim Biophys Acta. 2009. PMID: 19159610 Review.
• A biochemical approach to the problem of aging: "megaproject" on membrane-penetrating ions. The first results and prospects.
  Skulachev VP. Skulachev VP. Biochemistry (Mosc). 2007 Dec;72(12):1385-96. doi: 10.1134/s0006297907120139. Biochemistry (Mosc). 2007. PMID: 18205623 Review.
• Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals.
  Neroev VV, Archipova MM, Bakeeva LE, Fursova AZh, Grigorian EN, Grishanova AY, Iomdina EN, Ivashchenko ZhN, Katargina LA, Khoroshilova-Maslova IP, Kilina OV, Kolosova NG, Kopenkin EP, Korshunov SS, Kovaleva NA, Novikova YP, Philippov PP, Pilipenko DI, Robustova OV, Saprunova VB, Senin II, Skulachev MV, Sotnikova LF, Stefanova NA, Tikhomirova NK, Tsapenko IV, Shchipanova AI, Zinovkin RA, Skulachev VP. Neroev VV, et al. Biochemistry (Mosc). 2008 Dec;73(12):1317-28. doi: 10.1134/s0006297908120043. Biochemistry (Mosc). 2008. PMID: 19120017
• Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells.
  Agapova LS, Chernyak BV, Domnina LV, Dugina VB, Efimenko AY, Fetisova EK, Ivanova OY, Kalinina NI, Khromova NV, Kopnin BP, Kopnin PB, Korotetskaya MV, Lichinitser MR, Lukashev AL, Pletjushkina OY, Popova EN, Skulachev MV, Shagieva GS, Stepanova EV, Titova EV, Tkachuk VA, Vasiliev JM, Skulachev VP. Agapova LS, et al. Biochemistry (Mosc). 2008 Dec;73(12):1300-16. doi: 10.1134/s0006297908120031. Biochemistry (Mosc). 2008. PMID: 19120016
• Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies.
  Antonenko YN, Avetisyan AV, Bakeeva LE, Chernyak BV, Chertkov VA, Domnina LV, Ivanova OY, Izyumov DS, Khailova LS, Klishin SS, Korshunova GA, Lyamzaev KG, Muntyan MS, Nepryakhina OK, Pashkovskaya AA, Pletjushkina OY, Pustovidko AV, Roginsky VA, Rokitskaya TI, Ruuge EK, Saprunova VB, Severina II, Simonyan RA, Skulachev IV, Skulachev MV, Sumbatyan NV, Sviryaeva IV, Tashlitsky VN, Vassiliev JM, Vyssokikh MY, Yaguzhinsky LS, Zamyatnin AA Jr, Skulachev VP. Antonenko YN, et al. Biochemistry (Mosc). 2008 Dec;73(12):1273-87. doi: 10.1134/s0006297908120018. Biochemistry (Mosc). 2008. PMID: 19120014

Cited by

• Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes.
  Jin H, Kanthasamy A, Ghosh A, Anantharam V, Kalyanaraman B, Kanthasamy AG. Jin H, et al. Biochim Biophys Acta. 2014 Aug;1842(8):1282-94. doi: 10.1016/j.bbadis.2013.09.007. Epub 2013 Sep 20. Biochim Biophys Acta. 2014. PMID: 24060637 Free PMC article. Review.
• Novel mitochondria-targeted antioxidants: plastoquinone conjugated with cationic plant alkaloids berberine and palmatine.
  Lyamzaev KG, Pustovidko AV, Simonyan RA, Rokitskaya TI, Domnina LV, Ivanova OY, Severina II, Sumbatyan NV, Korshunova GA, Tashlitsky VN, Roginsky VA, Antonenko YN, Skulachev MV, Chernyak BV, Skulachev VP. Lyamzaev KG, et al. Pharm Res. 2011 Nov;28(11):2883-95. doi: 10.1007/s11095-011-0504-8. Epub 2011 Jun 14. Pharm Res. 2011. PMID: 21671134
• Current perspectives of mitochondria-targeted antioxidants in cancer prevention and treatment.
  Zinovkin RA, Lyamzaev KG, Chernyak BV. Zinovkin RA, et al. Front Cell Dev Biol. 2023 Mar 16;11:1048177. doi: 10.3389/fcell.2023.1048177. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37009472 Free PMC article. Review.
• A Review of Plant Extracts and Plant-Derived Natural Compounds in the Prevention/Treatment of Neonatal Hypoxic-Ischemic Brain Injury.
  Mohsenpour H, Pesce M, Patruno A, Bahrami A, Pour PM, Farzaei MH. Mohsenpour H, et al. Int J Mol Sci. 2021 Jan 15;22(2):833. doi: 10.3390/ijms22020833. Int J Mol Sci. 2021. PMID: 33467663 Free PMC article. Review.
• Mitochondria and cardiovascular aging.
  Dai DF, Rabinovitch PS, Ungvari Z. Dai DF, et al. Circ Res. 2012 Apr 13;110(8):1109-24. doi: 10.1161/CIRCRESAHA.111.246140. Circ Res. 2012. PMID: 22499901 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Biochemistry (Moscow)
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information